ATOX1 gene silencing increases susceptibility to anticancer therapy based on copper ionophores or chelating drugs

Journal of Inorganic Biochemistry
Vincenza BarresiDaniele Filippo Condorelli

Abstract

Copper is a catalytic cofactor required for the normal function of many enzymes involved in fundamental biological processes but highly cytotoxic when in excess. Therefore its homeostasis and distribution is strictly regulated by a network of transporters and intracellular chaperones. ATOX1 (antioxidant protein 1) is a copper chaperone that plays a role in copper homeostasis by binding and transporting cytosolic copper to ATPase proteins in the trans-Golgi network. In the present study the Caco-2 cell line, a colon carcinoma cell line, was used as an in vitro model to evaluate if ATOX1 deficiency could affect sensitivity to experimentally induced copper dyshomeostasis. Silencing of ATOX1 increased toxicity of a short treatment with a high concentration of Cu(2+). Copper ionophores, such as 5-chloro-8-hydroxyquinoline, induced a copper-dependent cell toxicity which was significantly potentiated after ATOX1 silencing. The copper chelator TPEN (N,N,N',N'-tetrakis (2-pyridylmethyl) ethylenediamine) produced a form of cell toxicity that was reversed by the addition of Cu(2+). ATOX1 silencing increased Caco-2 cell sensitivity to TPEN toxicity. Our results suggest the possibility of a therapy with copper-chelating or ionophore drugs i...Continue Reading

References

Feb 15, 1989·Cancer·M DìezJ L Balibrea
Sep 1, 1983·Cancer·E J MargaliothM Chevion
Apr 4, 1997·The Journal of Biological Chemistry·L W KlompJ D Gitlin
Jan 5, 2000·The Journal of Biological Chemistry·G S KelnerR A Maki
Jan 19, 2000·Trends in Biochemical Sciences·M D HarrisonC T Dameron
Mar 4, 2000·Nature Genetics·U ScherfJ N Weinstein
Dec 20, 2000·Proceedings of the National Academy of Sciences of the United States of America·S SperandioD E Bredesen
Dec 6, 2001·The Journal of Biological Chemistry·Jaekwon LeeDennis J Thiele
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Oct 9, 2002·Proceedings of the National Academy of Sciences of the United States of America·Seiko IshidaIra Herskowitz
Jan 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·Iqbal HamzaJonathan D Gitlin
Mar 12, 2005·Circulation Research·Viktoria JeneyTohru Fukai
Aug 8, 2006·Molecular Cancer Therapeutics·Wei-Qun DingStuart E Lind
Jul 10, 2007·The Biochemical Journal·Peter V E van den BergheLeo W J Klomp
Feb 5, 2008·The Journal of Biological Chemistry·Shinichi ItohTohru Fukai
Sep 2, 2008·The International Journal of Biochemistry & Cell Biology·Patricia A J Muller, Leo W J Klomp
Sep 25, 2008·Toxicology Letters·Xinliang Mao, Aaron D Schimmer
Jan 7, 2009·Journal of Inorganic Biochemistry·Roohangiz SafaeiStephen B Howell
Apr 11, 2009·Proceedings of the National Academy of Sciences of the United States of America·Michal ShefferEytan Domany
Apr 14, 2009·Toxicology and Applied Pharmacology·Takamitsu MiyayamaYasumitsu Ogra
Oct 8, 2009·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Shumei ZhaiBing Yan
Oct 28, 2009·IUBMB Life·Wei-Qun Ding, Stuart E Lind
Oct 30, 2009·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Reagan McRaeChristoph J Fahrni
Feb 2, 2010·Current Opinion in Chemical Biology·Svetlana Lutsenko
Mar 9, 2010·Annual Review of Biochemistry·Nigel J Robinson, Dennis R Winge
Jul 7, 2010·BMC Medical Genomics·Vincenza BarresiDaniele F Condorelli
Sep 8, 2010·Chemical Society Reviews·Sally L Pimlott, Andrew Sutherland
Dec 7, 2010·Chemical Society Reviews·Michael J WhitcombeAdrian Horgan
Dec 15, 2010·Chemical Society Reviews·Jae-Min OhJin-Ho Choy
Nov 15, 2011·Current Biology : CB·Richard A Festa, Dennis J Thiele
Jun 1, 2012·The Journal of Biological Chemistry·Yuta HatoriSvetlana Lutsenko
Dec 20, 2012·Antioxidants & Redox Signaling·Yuta Hatori, Svetlana Lutsenko

❮ Previous
Next ❯

Citations

Jul 22, 2018·The European Journal of Neuroscience·Changjiu Zhao, Stephen C Gammie
Aug 22, 2018·Journal of Cellular Biochemistry·Vincenza BarresiDaniele Filippo Condorelli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis